ICCM News and Press, IceCure Medical Ltd. From 01/18/23

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems PR Newswire Innovating as a global leader in cryoablation technologies, with 29 patents issued and allowed Cryogenic pump enables multip...

IceCure Medical ( NASDAQ: ICCM ) said on Tuesday it was publicly offering 8.79M shares priced at-the-market to the public of $1.65 per share. ( ICCM ) has risen ~9% before the bell. The gross proceeds, which is about $14.5M, will be used to fund the development of...

IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules PR Newswire CAESAREA, Israel , Dec. 23, 2022 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer o...

IceCure Medical Ltd. Announces Pricing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules PR Newswire CAESAREA, Israel , Dec. 21, 2022 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer o...

Top Tips to Use for Finding Penny Stocks to Buy Identifying penny stocks with high potential requires a combination of research, due diligence, and risk management. The key is to look for penny stocks that have strong fundamentals, are trading at a low price, and have the potential to gen...

IceCure Medical ( NASDAQ: ICCM ) on Tuesday announced the commencement of a proposed public offering of its ordinary shares. All of the securities to be sold in the offering are to be offered by IceCure. A.G.P./Alliance Global Partners is acting as lead placement agent for the...

IceCure Medical Ltd. Announces Proposed Public Offering PR Newswire CAESAREA, Israel , Dec. 20, 2022 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSen...

IceCure Medical ( NASDAQ: ICCM ) has risen four-folds after the company announced interim results from a study for its minimally-invasive cryoablation technology, the ProSense System that destroys tumors by freezing, to treat patients with small renal masses who cannot b...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: iQoncept / Shutterstock Sintx Technologies (NASDAQ: SINT ) stock is in the news Tuesday as the company enacted a reverse stock split when markets opened this morning. That reverse stock split has Sintx T...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Verona Pharma (NASDAQ: VRNA ) stock is rising higher on Tuesday after the company released results from a Phase 3 clinical trial . The big news here is the company’s Phase 3 ENHANCE-1 ...